GSK sees blockbuster potential in targeted cancer therapy after promising early data
By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer d...
12th April, 2026
By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer d...
12th April, 2026
By Michael Erman NEW YORK, April 7 (Reuters) - A top Bayer AG executive said on Tuesday the German d...
7th April, 2026
April 7 (Reuters) - Novo Nordisk said on Tuesday that it has made a higher-dose version of its block...
7th April, 2026
April 1 (Reuters) - UK's drug cost-effectiveness watchdog has recommended Novo Nordisk's Wegovy to r...
31st March, 2026
By Sneha S K March 31 (Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in...
31st March, 2026
By Maggie Fick, Bhanvi Satija and Dominique Patton LONDON/PARIS, March 31 (Reuters) - Drugmakers are...
31st March, 2026
March 30 (Reuters) - Eli Lilly wants the UK to regularly raise NHS drug prices and phase out a multi...
30th March, 2026
COPENHAGEN, March 26 (Reuters) - Novo Nordisk on Thursday elected Poul Weihrauch, CEO of family-owne...
26th March, 2026
By Nqobile Dludla JOHANNESBURG, March 25 (Reuters) - Novo Nordisk is cutting South African prices of...
25th March, 2026
By Bhanvi Satija and Michael Erman March 18 (Reuters) - U.S. President Donald Trump pledged to make...
18th March, 2026
BERLIN, March 16 (Reuters) - Swiss drugmaker Roche said on Monday it had expanded its artificial int...
16th March, 2026

By Gabriel Araujo and Luciana Magalhaes SAO PAULO, March 10 (Reuters) - Brazilian drugmaker EMS is o...
10th March, 2026